181 related articles for article (PubMed ID: 20971741)
21. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Bannerman B; Xu L; Jones M; Tsu C; Yu J; Hales P; Monbaliu J; Fleming P; Dick L; Manfredi M; Claiborne C; Bolen J; Kupperman E; Berger A
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1145-54. PubMed ID: 21400028
[TBL] [Abstract][Full Text] [Related]
23. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.
Sadzuka Y; Sugiyama T; Sonobe T
Toxicol Lett; 2000 Apr; 114(1-3):155-62. PubMed ID: 10713480
[TBL] [Abstract][Full Text] [Related]
24. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
25. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
[TBL] [Abstract][Full Text] [Related]
27. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
29. Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.
Stearns ME; Wang M
Transl Oncol; 2011 Jun; 4(3):147-56. PubMed ID: 21633670
[TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
31. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
32. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.
Shukla R; Chanda N; Zambre A; Upendran A; Katti K; Kulkarni RR; Nune SK; Casteel SW; Smith CJ; Vimal J; Boote E; Robertson JD; Kan P; Engelbrecht H; Watkinson LD; Carmack TL; Lever JR; Cutler CS; Caldwell C; Kannan R; Katti KV
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12426-31. PubMed ID: 22802668
[TBL] [Abstract][Full Text] [Related]
33. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells.
Milligan SA; Burke P; Coleman DT; Bigelow RL; Steffan JJ; Carroll JL; Williams BJ; Cardelli JA
Clin Cancer Res; 2009 Aug; 15(15):4885-94. PubMed ID: 19638461
[TBL] [Abstract][Full Text] [Related]
34. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Sanna V; Singh CK; Jashari R; Adhami VM; Chamcheu JC; Rady I; Sechi M; Mukhtar H; Siddiqui IA
Sci Rep; 2017 Feb; 7():41573. PubMed ID: 28145499
[TBL] [Abstract][Full Text] [Related]
35. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
[TBL] [Abstract][Full Text] [Related]
36. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
Shankar S; Marsh L; Srivastava RK
Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria.
Yang J; Yu H; Sun S; Zhang L; Das UN; Ruan H; He G; Shen S
Biol Trace Elem Res; 2009 Dec; 131(3):298-310. PubMed ID: 19326061
[TBL] [Abstract][Full Text] [Related]
38. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.
Wang P; Heber D; Henning SM
Nutr Cancer; 2012; 64(4):580-7. PubMed ID: 22452782
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.
Yu HN; Shen SR; Xiong YK
J Zhejiang Univ Sci B; 2005 Feb; 6(2):125-31. PubMed ID: 15633248
[TBL] [Abstract][Full Text] [Related]
40. Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line.
Kim MH; Chung J
Anticancer Res; 2007; 27(6B):3947-56. PubMed ID: 18225555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
